Kerri Fitzgerald
Kerri Fitzgerald
Kerri Fitzgerald is a medical writer and editor with over 10 years of experience writing mostly in the hematology/oncology space. She can be reached at kfitzgerald@mashupmd.com.
Articles by Kerri Fitzgerald
The results were presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
Just 38% of patients with breast cancer receive at least 1 palliative care consult following metastatic disease diagnosis.
All stakeholders have a role to play in increasing representation in this patient population.
A study identified self-reported gaps from healthcare providers associated with providing treatment-related support.
A study published in Kidney International Reports found that kidney involvement is heterogenous in patients with chronic ...
A study published in Transplant and Cellular Therapy assessed outcomes in patients with myelofibrosis (MF) who choose to ...
A study published in Hematology/Oncology and Stem Cell Therapy observed no significant difference in the rate of thrombotic ...
Decitabine with or without ruxolitinib is beneficial for patients with advanced myeloproliferative neoplasms (MPN) when ...
A study presented as part of the ASH 2020 Annual Meeting found that use of fedratinib for 24 or more weeks was well-tolerated ...
Interferon-alpha (rIFN?) is the only disease-modifying treatment option for polycythemia vera (PV). A study published in ...
The Janus kinase (JAK) inhibitor ruxolitinib was U.S. Food and Drug Administration-approved for patients with high-risk ...
A study presented as part of the ASH 2020 Annual Meeting found that imetelstat improved overall survival (OS) in patients ...
A study presented at the 2021 Transplantation and Cellular Therapy Meetings found that peri-transplant ruxolitinib was safe ...
A study published in Blood Advances observed a high risk of recurrent thrombotic events in patients with myeloproliferative ...
A study published in Hematological Oncology found that overweight/obese patients with polycythemia vera (PV) do not have an ...
A study published in Hematology/Oncology and Stem Cell Therapy did not observe a significant difference in the rate of ...
A study published in the American Journal of Blood Research observed a link between serum ferritin level and fibrosis in ...
Pulmonary hypertension is common in patients with Philadelphia?chromosome negative myeloproliferative neoplasms (MPN). ...
The effect of bone marrow (BM) blasts on the outcome of patients with myelofibrosis (MF) is poorly understood, except for in ...
The CALR mutation has prognostic value for the stratification of thrombotic risk in patients with essential thrombocytopenia ...
670 Madison Ave.
Manalapan, NJ 07726